Evolv Technologies Holdings, Inc.
Stockholder Alert: Robbins LLP Reminds EVLV Stockholders of Upcoming May 24, 2024 Lead Plaintiff Deadline in the Evolv Technologies Holdings, Inc. Class Action
May 09, 2024 15:17 ET | Robbins LLP
Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Evolv Technologies Holdings, Inc investors: Please contact the Portnoy Law Firm to recover your losses; May 24, 2024 deadline
May 01, 2024 18:49 ET | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Evolv Technologies Holdings,...
Evolv Technologies Holdings, Inc.
EVLV Stockholders Should Contact Robbins LLP for Information about the Evolv Technologies Holdings, Inc. Class Action
April 15, 2024 16:51 ET | Robbins LLP
Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
Evolv Technologies Holdings, Inc.
EVLV Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Evolv Technologies Holdings, Inc. Class Action
April 05, 2024 13:27 ET | Robbins LLP
Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Evolv Technologies Holdings, Inc investors: Please contact the Portnoy Law Firm to recover your losses; May 24, 2024 deadline
March 26, 2024 17:02 ET | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Evolv Technologies Holdings,...
Evolv Technologies Holdings, Inc.
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Evolv Technologies Holdings, Inc. f/k/a Newhold Investment Corp.
March 26, 2024 15:56 ET | Robbins LLP
Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products